Author:
Tomuta Ioan,Porfire Alina
Publisher
Springer International Publishing
Reference166 articles.
1. Alhijjaj M, Belton P, Qi S. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur J Pharm Biopharm. 2016;108:111–25. https://doi.org/10.1016/j.ejpb.2016.08.016.
2. Ali S, Kolter K, Karl M. Evaluation of different polymers in 3D printing technologies. Am Pharm Rev. 2019; https://www.americanpharmaceuticalreview.com/Featured-Articles/518798-Evaluation-of-Different-Polymers-in-3D-Printing-Technologies/
3. Allahham N, Fina F, Marcuta C, et al. Selective laser sintering 3D printing of orally disintegrating printlets containing ondansetron. Pharmaceutics. 2020;12(2):1–13. https://doi.org/10.3390/pharmaceutics12020110.
4. Alomari M, Mohamed FH, Basit AW, Gaisford S. Personalised dosing: printing a dose of one’s own medicine. Int J Pharm. 2015;494(2):568–77. https://doi.org/10.1016/j.ijpharm.2014.12.006.
5. Ashland Inc. KLUCEL hydroxypropylcellulose physical and chemical properties (datasheet). Covington; 2017. http://www.ashland.com/file_source/Ashland/Product/Documents/Pharmaceutical/PC_11229_Klucel_HPC.pdf